JP2024539458A5 - - Google Patents
Info
- Publication number
- JP2024539458A5 JP2024539458A5 JP2024529784A JP2024529784A JP2024539458A5 JP 2024539458 A5 JP2024539458 A5 JP 2024539458A5 JP 2024529784 A JP2024529784 A JP 2024529784A JP 2024529784 A JP2024529784 A JP 2024529784A JP 2024539458 A5 JP2024539458 A5 JP 2024539458A5
- Authority
- JP
- Japan
- Prior art keywords
- mouse
- sequence
- stmn2
- human
- exon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163282023P | 2021-11-22 | 2021-11-22 | |
| US63/282,023 | 2021-11-22 | ||
| PCT/US2022/080224 WO2023092118A1 (en) | 2021-11-22 | 2022-11-21 | Methods and compositions relating to humanized stathmin2 mouse model with disrupted tdp-43 binding sites |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539458A JP2024539458A (ja) | 2024-10-28 |
| JP2024539458A5 true JP2024539458A5 (https=) | 2025-11-13 |
Family
ID=86397888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024529784A Pending JP2024539458A (ja) | 2021-11-22 | 2022-11-21 | 破壊されたｔｄｐ－４３結合部位を有するヒト化スタスミン２マウスモデルに関連する方法および組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250040523A1 (https=) |
| EP (1) | EP4436586A4 (https=) |
| JP (1) | JP2024539458A (https=) |
| KR (1) | KR20240116486A (https=) |
| CN (1) | CN118284707A (https=) |
| IL (1) | IL312770A (https=) |
| WO (1) | WO2023092118A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120519523A (zh) * | 2025-05-21 | 2025-08-22 | 首都医科大学附属北京天坛医院 | 一种基于Sptlc-E260K点突变构建的ALS小鼠模型及其构建方法和用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120192298A1 (en) * | 2009-07-24 | 2012-07-26 | Sigma Aldrich Co. Llc | Method for genome editing |
| AU2020466994A1 (en) * | 2019-09-17 | 2022-04-21 | Rutgers, The State University Of New Jersey | Highly efficient DNA base editors mediated by RNA-aptamer recruitment for targeted genome modification and uses thereof |
-
2022
- 2022-11-21 IL IL312770A patent/IL312770A/en unknown
- 2022-11-21 WO PCT/US2022/080224 patent/WO2023092118A1/en not_active Ceased
- 2022-11-21 CN CN202280077093.0A patent/CN118284707A/zh active Pending
- 2022-11-21 US US18/711,686 patent/US20250040523A1/en active Pending
- 2022-11-21 EP EP22896792.3A patent/EP4436586A4/en active Pending
- 2022-11-21 JP JP2024529784A patent/JP2024539458A/ja active Pending
- 2022-11-21 KR KR1020247020449A patent/KR20240116486A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Loganathan et al. | Non-coding RNAs in human health and disease: potential function as biomarkers and therapeutic targets | |
| Rakers et al. | Stroke target identification guided by astrocyte transcriptome analysis | |
| Duan et al. | Brain-wide Cas9-mediated cleavage of a gene causing familial Alzheimer’s disease alleviates amyloid-related pathologies in mice | |
| CN114634930B (zh) | 使用rna指导型内切核酸酶改善基因组工程特异性的组合物和方法 | |
| Jia et al. | The effects of pharmacological inhibition of histone deacetylase 3 (HDAC3) in Huntington’s disease mice | |
| US20250161485A1 (en) | Aav capsid variants and uses thereof | |
| US20260085095A1 (en) | Aav capsid variants and uses thereof | |
| JP2019500349A5 (https=) | ||
| JP2009537129A (ja) | エキソンスキッピングを誘発する為の手段及び方法 | |
| EP3212788A2 (en) | Compositions, methods and use of synthetic lethal screening | |
| JP2008538500A (ja) | ＳＲタンパク質の結合に対する干渉とＲＮＡ二次構造に対する干渉による、ｍＲＮＡ前駆体におけるエクソン認識の調節 | |
| KR20210010549A (ko) | 스플라이싱이상을 감소시키고 rna 우성 질환을 치료하기 위한 조성물 및 방법 | |
| WO2024006741A1 (en) | Aav capsid variants and uses thereof | |
| JP2024539458A5 (https=) | ||
| US20250388626A1 (en) | Aav capsid variants and uses thereof | |
| WO2025038430A1 (en) | Aav capsid variants and uses thereof | |
| Alizadeh et al. | Production of duchenne muscular dystrophy cellular model using crispr-cas9 exon deletion strategy | |
| Flynn et al. | Synthetic dosage-compensating miRNA circuits allow precision gene therapy for Rett syndrome | |
| You et al. | Genome-wide profiling reveals functional diversification of∆ FosB gene targets in the hippocampus of an Alzheimer's disease mouse model | |
| US20240108755A1 (en) | Compositions and methods for treating a neurodegenerative or developmental disorder | |
| Inoue et al. | Amplification of 4 ‘-ThioDNA in the presence of 4 ‘-Thio-dTTP and 4 ‘-Thio-dCTP, and 4 ‘-ThioDNA-directed transcription in vitro and in mammalian cells | |
| Lee et al. | DNA regulatory element cooperation and competition in transcription | |
| WO2025147436A1 (en) | Aav capsid variants and uses thereof | |
| JP2024539458A (ja) | 破壊されたｔｄｐ－４３結合部位を有するヒト化スタスミン２マウスモデルに関連する方法および組成物 | |
| US20220106598A1 (en) | Homologous recombination directed genome editing in eukaryotes |